Iteris Incorporated New (ITI) Forecast, Price Target & Analyst Ratings

NASDAQ:ITIUS46564T1079

Current stock price

7.19 USD
-0.01 (-0.14%)
At close:
7.19 USD
0 (0%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Iteris Incorporated New (ITI).

Forecast Snapshot

Consensus Price Target

Price Target
$7.34
+ 2.14% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Feb 6, 2025
Period
Q2 / 2025
EPS Estimate
$0.03
Revenue Estimate
47.205M

ChartMill Buy Consensus

Rating
46.67%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.34
Upside
+ 2.14%
From current price of $7.19 to mean target of $7.34, Based on 9 analyst forecasts
Low
$7.27
Median
$7.34
High
$7.56

Price Target Revisions

1 Month
0.00%
3 Months
-20.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for ITI. The average price target is 7.34 USD. This implies a price increase of 2.14% is expected in the next year compared to the current price of 7.19.
The average price target has been revised downward by 20% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

ITI Current Analyst RatingITI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ITI Historical Analyst RatingsITI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
46.67%
ITI was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about ITI.
In the previous month the buy percentage consensus was at a similar level.
ITI was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-08-21B. Riley SecuritiesDowngrade Buy -> Neutral
2024-08-12Maxim GroupDowngrade Buy -> Hold
2024-06-14EF HuttonMaintains Buy -> Buy
2024-04-30Maxim GroupInitiate Buy
2024-03-20EF HuttonReiterate Buy -> Buy
2024-03-12EF HuttonMaintains Buy -> Buy
2024-02-12EF HuttonMaintains Buy -> Buy
2024-02-09B. Riley SecuritiesMaintains Buy -> Buy
2023-08-10B. Riley SecuritiesMaintains Buy -> Buy
2023-08-09EF HuttonReiterate Buy -> Buy
2023-06-14EF HuttonReiterate Buy -> Buy
2023-04-27Northland Capital MarketsMaintains Outperform
2023-02-06EF HuttonMaintains Buy
2023-02-03B. Riley SecuritiesMaintains Buy
2022-11-21EF HuttonInitiate Buy
2022-06-02B. Riley SecuritiesMaintains Buy
2022-02-04Craig-HallumDowngrade Buy -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
Feb 6, 2025
Period
Q2 / 2025
EPS Estimate
$0.03
Revenue Estimate
47.205M
Revenue Q2Q
8.36%
EPS Q2Q
203.00%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.50%
Revenue (3 Months)
-2.19%
EPS (1 Month)
12.49%
EPS (3 Months)
-47.06%

Next Earnings Summary

ITI is expected to report earnings on 2/6/2025. The consensus EPS estimate for the next earnings is 0.03 USD and the consensus revenue estimate is 47.20M USD.
The next earnings revenue estimate has been revised downward by 2.19% in the past 3 months.

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ITI revenue by date.ITI revenue by date.
133.6M
14.09%
156.1M
16.84%
171.987M
10.18%
190.96M
11.03%
216.91M
13.59%
245.44M
13.15%
EBITDA
YoY % growth
ITI ebitda by date.ITI ebitda by date.
-1.94M
-146.52%
-10M
-415.46%
6.663M
166.63%
15.874M
138.24%
24.479M
54.21%
31.837M
30.06%
EBIT
YoY % growth
ITI ebit by date.ITI ebit by date.
-6M
-528.57%
-13.8M
-130.00%
2.819M
120.43%
8.279M
193.69%
16.937M
104.58%
21.113M
24.66%
Operating Margin
ITI operating margin by date.ITI operating margin by date.
-4.49%-8.84%1.64%4.34%7.81%8.60%
EPS
YoY % growth
ITI eps by date.ITI eps by date.
-0.16
-164.00%
-0.34
-112.50%
0.07
120.59%
0.18
159.71%
0.33
83.33%
0.58
72.73%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.03
203.00%
0.05
405.00%
0.07
Revenue
Q2Q % growth
47.205M
8.36%
47.521M
12.80%
49.036M
14.70%
EBITDA
Q2Q % growth
3.227M
38.50%
4.138M
30.74%
5.171M
34.38%
EBIT
Q2Q % growth
1.174M
149.79%
2.447M
521.07%
3.491M
87,175.00%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ITI Yearly Revenue VS EstimatesITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
ITI Yearly EPS VS EstimatesITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
101.85%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
12.26%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
96.04%
EBIT Next 5 Year
N/A

Iteris Incorporated New / ITI Forecast FAQ

What is the average price target for Iteris Incorporated New (ITI) stock?

9 analysts have analysed ITI and the average price target is 7.34 USD. This implies a price increase of 2.14% is expected in the next year compared to the current price of 7.19.

Can you provide the upcoming earnings date for Iteris Incorporated New?

Iteris Incorporated New (ITI) will report earnings on 2025-02-06, after the market close.

What are the consensus estimates for Iteris Incorporated New (ITI) next earnings?

The consensus EPS estimate for the next earnings of Iteris Incorporated New (ITI) is 0.03 USD and the consensus revenue estimate is 47.20M USD.

Can you provide the consensus rating for Iteris Incorporated New stock?

The consensus rating for Iteris Incorporated New (ITI) is 46.6667 / 100 . This indicates that analysts generally have a neutral outlook on the stock.